Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies

Abstract The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Puneet Rawat, Divya Sharma, Ambuj Srivastava, Vani Janakiraman, M. Michael Gromiha
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/91d1b92f687040aebb2d043b3dfc7e60
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!